Nirmal Verma

Nirmal Verma

Auto-generated profile, based on publicly available information

Nirmal Verma

Department of Pharmacology and Nutritional Sciences, College of Medicine, University of Kentucky, Lexington, KY, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2017 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
HLHan Ly
Han Ly
NVNirmal Verma
Nirmal Verma
FWFengen Wu
Fengen Wu
MLMiao Liu
Miao Liu
KSKathryn E. Saatman
Kathryn E. Saatman
FDFlorin Despa
Florin Despa

22 June 2016 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
NVNirmal Verma
Nirmal Verma
HLHan Ly
Han Ly
MLMiao Liu
Miao Liu
JCJing Chen
Jing Chen
HZHaining Zhu
Haining Zhu
FDFlorin Despa
Florin Despa
Amylin is a hormone synthesized and co-secreted with insulin by pancreatic β-cells that crosses the blood-brain barrier and regulates satiety. Amylin from humans (but not rodents) has an increased propensity to aggregate into pancreatic islet amyloid

1 January 2020 in Kidney International
Verified
Journal Article
Closed access
NVNirmal Verma
Nirmal Verma
MLMiao Liu
Miao Liu
HLHan Ly
Han Ly
ALAnalia Loria
Analia Loria
KCKenneth S. Campbell
Kenneth S. Campbell
FDFlorin Despa
Florin Despa

22 June 2016 in Diabetes
Verified
Journal Article
Open access
PDF file
MLMiao Liu
Miao Liu
NVNirmal Verma
Nirmal Verma
XPXiaoli Peng
Xiaoli Peng
SSSarah Srodulski
Sarah Srodulski
AMAndrew Morris
Andrew Morris
FDFlorin Despa
Florin Despa
Hypersecretion of amylin is common in individuals with prediabetes, causes amylin deposition and proteotoxicity in pancreatic islets, and contributes to the development of type 2 diabetes. Recent studies also identified amylin deposits in failing hearts from patients with obesity or type 2 diabetes and demonstrated that hyperamylinemia accelerates the development of heart dysfunction in rats expressing human amylin in pancreatic β-cells (HIP rats). To further determine the impact of hyperamylinemia on cardiac myocytes, we investigated human myocardium, compared diabetic HIP rats with diabetic rats expressing endogenous (nonamyloidogenic) rat amylin, studied normal mice injected with aggregated human amylin, and developed in vitro cell models. We found that amylin deposition negatively affects cardiac myocytes by inducing sarcolemmal injury, generating reactive aldehydes, forming amylin-based adducts with reactive aldehydes, and increasing synthesis of the proinflammatory cytokine interleukin-1β (IL-1β) independently of hyperglycemia. These results are consistent with the pathological role of amylin deposition in the pancreas, uncover a novel contributing mechanism to cardiac myocyte injury in type 2 diabetes, and suggest a potentially treatable link of type 2 diabetes with diabetic heart disease. Although further studies are necessary, these data also suggest that IL-1β might function as a sensor of myocyte amylin uptake and a potential mediator of myocyte injury.

1 January 2019 in Diabetes & Metabolism Journal
Verified
Journal Article
Open access
PDF file
NVNirmal Verma
Nirmal Verma
FDFlorin Despa
Florin Despa
The link of diabetes with co-occurring disorders in the brain involves complex and multifactorial pathways. Genetically engineered rodents that express familial Alzheimer's disease-associated mutant forms of amyloid precursor protein and presenilin 1 (PSEN1) genes provided invaluable insights into the mechanisms and consequences of amyloid deposition in the brain. Adding diabetes factors (obesity, insulin impairment) to these animal models to predict success in translation to clinic have proven useful at some extent only. Here, we focus on contributing factors to diabetic brain injury with the aim of identifying appropriate animal models that can be used to mechanistically dissect the pathophysiology of diabetes-associated cognitive dysfunction and how diabetes medications may influence the development and progression of cognitive decline in humans with diabetes.

1 May 2018 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
MLMiao Liu
Miao Liu
AHAmanda Hoskins
Amanda Hoskins
NVNirmal Verma
Nirmal Verma
DBDonald M. Bers
Donald M. Bers
SDSanda Despa
Sanda Despa
FDFlorin Despa
Florin Despa